Bruce Booth
Board Member
Kymera Therapeutics, Inc. (KYMR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bruce Booth
Bruce Booth is recorded as Board Member at Kymera Therapeutics, Inc. (KYMR). Bruce Booth was last confirmed as Board Member at Sionna Therapeutics, Inc. (SION) in a filing dated April 29, 2025. Earlier roles on record: Board Member at Cogent Biosciences, Inc. (COGT) until July 6, 2020, Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) until September 11, 2023 and Board Member at Tectonic Therapeutic, Inc. (TECX) until June 20, 2024. Tectonic Therapeutic, Inc. reported in an 8-K filed June 20, 2024 that Bruce Booth resigned as member of the board of directors, effective June 20, 2024. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Bruce Booth resigned as Board of Directors, effective September 11, 2023.
“In accordance with the Merger Agreement, immediately prior to the Merger, Gail Farfel, Ph.D., Christopher Paige, Ph.D., Philip J. Vickers, Ph.D., Ian Clark, Annalisa Jenkins, M.B.B.S., F.R.C.P. and Bruce Booth, D.Phil. resigned from the AVROBIO's board of directors and committees of the AVROBIO board of directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to its operations, policies or practices.”
“In accordance with the Merger Agreement, immediately prior to and effective upon the closing of the Merger, Jeffrey W. Albers, Bruce Booth, D. Phil., Thomas O. Daniel, M.D., Amy Lynn Ronneberg, David T. Scadden, M.D. and Michael Vasconcelles, M.D. resigned from the Board of Directors and committees of the Board of Directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2015-01-01–present
-
2016-01-01–2024-06-20
-
Start not stated–2025-04-29
Last confirmed by a filing; no departure on record
-
Start not stated–2020-07-06
-
Start not stated–2023-09-11
-
Start not stated–2023-09-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kymera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jeremy Chadwick, Ph.D. COO
- Brian R. Adams General Counsel
- Brian R. Adams, J.D. General Counsel
- Brian Adams Board Member
- Bruce Jacobs Board Member
- Elena Ridloff Board Member
- Felix J. Baker, Ph.D. Board Member
- Gorjan Hrustanovic, Ph.D. Board Member
- Jared Gollob Board Member
- Jeremy Chadwick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.